Phase I/IIA Study of CART19 Cells for Patients With Chemotherapy Resistant or Refractory CD19+ Leukemia and Lymphoma
Clinical trial NCT01626495 · COMPLETED
Trial details
- NCT number
- NCT01626495
- Sponsor
- University of Pennsylvania
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-17
- Primary completion
- 2018-05-07
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.